|
ES2293638T3
(es)
|
1994-03-25 |
2008-03-16 |
Isotechnika, Inc. |
Mejora de la eficacia de farmacos por deuteracion.
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
US5919785A
(en)
|
1996-04-03 |
1999-07-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
AU2002365057A1
(en)
|
2001-12-21 |
2003-07-30 |
Cytokinetics, Inc. |
Compositions and methods for treating heart failure
|
|
ATE552236T1
(de)
|
2003-01-14 |
2012-04-15 |
Cytokinetics Inc |
Verbindungen, zusammensetzungen und verfahren zur behandlung von herzinsuffizienz
|
|
EP1605752B1
(en)
|
2003-03-27 |
2011-09-14 |
Cytokinetics, Inc. |
Sulfonamides for the treatment of congestive heart failure, their compositions and uses.
|
|
EP1621540A4
(en)
|
2003-04-21 |
2008-07-23 |
Ono Pharmaceutical Co |
HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN AND USE THEREOF
|
|
ES2522579T3
(es)
|
2004-06-17 |
2014-11-17 |
Cytokinetics, Inc. |
Compuestos, composiciones y métodos
|
|
JP2008521900A
(ja)
|
2004-11-30 |
2008-06-26 |
アムジエン・インコーポレーテツド |
キノリン及びキナゾリン類似体並びにがん治療のための医薬としてのその使用
|
|
US20060173183A1
(en)
|
2004-12-31 |
2006-08-03 |
Alantos Pharmaceuticals, Inc., |
Multicyclic bis-amide MMP inhibitors
|
|
TW200718692A
(en)
|
2005-04-22 |
2007-05-16 |
Wyeth Corp |
Dihydrobenzofuran derivatives and uses thereof
|
|
WO2007078815A2
(en)
|
2005-12-16 |
2007-07-12 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
RU2318818C1
(ru)
|
2006-04-12 |
2008-03-10 |
Общество С Ограниченной Ответственностью "Исследовательский Институт Химического Разнообразия" |
Азагетероциклы, комбинаторная библиотека, фокусированная библиотека, фармацевтическая композиция и способ получения (варианты)
|
|
SA08290245B1
(ar)
|
2007-04-23 |
2012-02-12 |
استرازينيكا ايه بي |
مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
|
|
US20090192168A1
(en)
|
2008-01-04 |
2009-07-30 |
Alex Muci |
Compounds, Compositions and Methods
|
|
NZ596302A
(en)
|
2009-05-15 |
2014-01-31 |
Novartis Ag |
Aryl pyridine as aldosterone synthase inhibitors
|
|
US8592426B2
(en)
|
2011-01-24 |
2013-11-26 |
Hoffmann—La Roche Inc. |
Aryl-benzocycloalkyl amide derivatives
|
|
US8759380B2
(en)
|
2011-04-22 |
2014-06-24 |
Cytokinetics, Inc. |
Certain heterocycles, compositions thereof, and methods for their use
|
|
US9409917B2
(en)
|
2012-01-20 |
2016-08-09 |
Actelion Pharmaceuticals Ltd. |
Heterocyclic amide derivatives as P2X7 receptor antagonists
|
|
SMT202000071T1
(it)
|
2013-06-21 |
2020-03-13 |
Myokardia Inc |
Composti di pirimidinadione contro le condizioni cardiache
|
|
US9199945B2
(en)
|
2013-06-21 |
2015-12-01 |
MyoKardia, Inc. |
Cycloalkyl-substituted pyrimidinedione compounds
|
|
US9663516B2
(en)
|
2014-12-18 |
2017-05-30 |
MyoKardia, Inc. |
Bicyclic-pyrimidinedione compounds
|
|
CN104539229A
(zh)
|
2014-12-26 |
2015-04-22 |
金海新源电气江苏有限公司 |
一种太阳能光伏支架
|
|
EP4234017B1
(en)
|
2015-01-22 |
2026-04-15 |
MyoKardia, Inc. |
Preparation of 4-methylsulfonyl-substituted piperidine urea compounds useful for the treatment of cardiac disorders such as dilated cardiomyopathy (dcm)
|
|
JP2019507110A
(ja)
|
2015-12-17 |
2019-03-14 |
シンジェンタ パーティシペーションズ アーゲー |
殺微生物性オキサジアゾール誘導体
|
|
CN108368098B
(zh)
|
2015-12-18 |
2022-01-28 |
先正达参股股份有限公司 |
杀微生物的噁二唑衍生物
|
|
CA3022432A1
(en)
|
2016-04-29 |
2017-11-02 |
Board Of Regents, The University Of Texas System |
Sigma receptor binders
|
|
WO2017222951A1
(en)
|
2016-06-23 |
2017-12-28 |
Merck Sharp & Dohme Corp. |
3-aryl and heteroaryl substituted 5-trifluoromethyl oxadiazoles as histone deacetylase 6 (hdac6) inhibitors
|
|
JP6681517B2
(ja)
|
2016-09-27 |
2020-04-15 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
ｍＧｌｕＲ２陰性アロステリック調節剤としてのクロマン、イソクロマン及びジヒドロイソベンゾフラン誘導体、組成物、及びそれらの使用
|
|
WO2018089433A1
(en)
|
2016-11-08 |
2018-05-17 |
Navitor Pharmaceuticals, Inc. |
PHENYL mTORC INHIBITORS AND USES THEREOF
|
|
WO2018156883A1
(en)
|
2017-02-23 |
2018-08-30 |
Board Of Regents, The University Of Texas System |
Methods of treatment for cancer, sterol homeostasis, and neurological diseases
|
|
CA3071948A1
(en)
|
2017-08-04 |
2019-02-07 |
MyoKardia, Inc. |
Mavacamten for use in the treatment of hypertrophic cardiomyopathy
|
|
WO2019144041A1
(en)
|
2018-01-19 |
2019-07-25 |
Cytokinetics, Inc. |
Dihydrobenzofuran and inden analogs as cardiac sarcomere inhibitors
|
|
BR112020018094A2
(pt)
|
2018-03-08 |
2020-12-22 |
Incyte Corporation |
Compostos de aminopirazina diol como inibidores de pi3k-¿
|
|
US10710994B2
(en)
|
2018-03-19 |
2020-07-14 |
Genentech, Inc. |
Oxadiazole transient receptor potential channel inhibitors
|
|
JP7610985B2
(ja)
|
2018-06-26 |
2025-01-09 |
サイトキネティックス， インコーポレイテッド |
心臓サルコメア阻害剤
|
|
JP7438148B2
(ja)
|
2018-06-26 |
2024-02-26 |
サイトキネティックス， インコーポレイテッド |
心臓サルコメア阻害剤
|
|
MX2021001380A
(es)
|
2018-08-31 |
2021-05-27 |
Xenon Pharmaceuticals Inc |
Compuestos de sulfonamida sustituidos con heteroarilo y su uso como agentes terapeuticos.
|
|
MA53491A
(fr)
|
2018-08-31 |
2021-09-15 |
Cytokinetics Inc |
Inhibiteurs de sarcomes cardiaques
|
|
EA202191152A1
(ru)
|
2018-10-29 |
2022-01-19 |
Миокардиа, Инк. |
Тетрагидропиран (thp)-замещенные бициклические соединения пиримидиндиона
|
|
RS65302B1
(sr)
|
2019-07-17 |
2024-04-30 |
Cytokinetics Inc |
Oralne formulacije inhibitora srčanog sarkomera
|
|
EP3999180B1
(en)
|
2019-07-17 |
2024-05-08 |
Cytokinetics, Inc. |
Polymorphs of (r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide
|
|
EP4054588A4
(en)
|
2019-11-10 |
2023-12-13 |
MyoKardia, Inc. |
Methods of treatment with myosin modulator
|
|
MX2023002024A
(es)
|
2020-08-28 |
2023-05-10 |
Myokardia Inc |
Métodos de tratamiento con modulador de miosina.
|
|
CN114456163B
(zh)
|
2020-11-09 |
2023-08-11 |
江苏恒瑞医药股份有限公司 |
四氢吡啶并嘧啶二酮类衍生物、其制备方法及其在医药上的应用
|
|
CN114516843B
(zh)
|
2020-11-19 |
2024-10-22 |
江苏恒瑞医药股份有限公司 |
嘧啶二酮类衍生物、其制备方法及其在医药上的应用
|
|
WO2022105852A1
(zh)
|
2020-11-20 |
2022-05-27 |
江苏恒瑞医药股份有限公司 |
三嗪二酮类衍生物、其制备方法及其在医药上的应用
|
|
CN116507621B
(zh)
|
2020-11-24 |
2025-10-17 |
江苏恒瑞医药股份有限公司 |
嘧啶二酮类衍生物、其制备方法及其在医药上的应用
|
|
CN114539257B
(zh)
|
2020-11-24 |
2023-08-11 |
江苏恒瑞医药股份有限公司 |
嘧啶二酮类螺环衍生物、其制备方法及其在医药上的应用
|
|
CN114539229B
(zh)
|
2020-11-24 |
2024-10-22 |
江苏恒瑞医药股份有限公司 |
嘧啶二酮类衍生物、其制备方法及其在医药上的应用
|
|
TWI820622B
(zh)
|
2021-03-04 |
2023-11-01 |
美商美國禮來大藥廠 |
Fgfr3抑制劑化合物
|
|
CN117083275A
(zh)
|
2021-03-04 |
2023-11-17 |
赛特凯恩蒂克公司 |
心脏肌节抑制剂
|
|
RS67793B1
(sr)
|
2022-09-02 |
2026-03-31 |
Cytokinetics Inc |
Kristalni oblici 5-(3,4-difluorbenzil)-8-((1r,4r)-4-metilcikloheksil)-6,9-diokso-2,5,8-triazapiro[3.5]nonan-2-karbaldehida
|